TALOPH(SH:600222) Zheng Quan Zhi Xing·2025-07-17 10:22Core Viewpoint - The legal opinion letter confirms that the second extraordinary general meeting of shareholders of Henan Tailong Pharmaceutical Co., Ltd. in 2025 was convened and conducted in accordance with relevant laws and regulations, ensuring the legality and validity of the meeting and its resolutions [10]. Group 1: Meeting Procedures - The meeting was convened following the proposal to apply for the registration of short-term financing bonds and the decision to hold the second extraordinary general meeting of shareholders in 2025 [2]. - The meeting notification was published on the stock exchange website, detailing the meeting's basic information, including type, convenor, voting methods, and important dates [3]. - The meeting was held at the designated location and was presided over by the chairman, Mr. Yin Hui, utilizing both on-site and online voting methods [3][4]. Group 2: Attendance and Qualifications - The convenor of the meeting was the company's board of directors, whose qualifications were confirmed to be in compliance with relevant laws and regulations [5]. - A total of 3 shareholders and their representatives attended the meeting, holding 143,474,602 voting shares, which accounted for 25.9483% of the total voting shares [6]. - The online voting was conducted through the Shanghai Stock Exchange's system, with 484 participants representing 15,866,371 shares, or 2.8695% of the total voting shares [6]. Group 3: Agenda and Voting Results - The agenda for the meeting included the proposal to apply for the registration of short-term financing bonds, which was adequately disclosed in the meeting notification [7]. - The voting results showed that 156,785,472 shares were in favor of the proposal, 2,017,101 shares were against, and 538,400 shares abstained, indicating a strong majority in favor [9]. - The voting procedures and results were confirmed to comply with relevant laws and regulations, ensuring the legitimacy of the resolutions passed during the meeting [9][10].